Please log in to see the full text of this API!

Erdafitinib

  • Synonyms: JNJ-42756493; JNJ-493; G-024
  • ATC: -
  • Use: Lorem 
  • Chemical name: Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam
  • Formula: Lorem ipsum dolor sit amet,
  • MW:446.6 g/mol
  • CAS-RN:1346242-81-6
  • InChI Key:OLAHOMJCDNXHFI-UHFFFAOYSA-N
  • InChI:InChI=1S/C25H30N6O2/c1-17(2)26-8-9-31(20-10-21(32-4)13-22(11-20)33-5)19-6-7-23-24(12-19)29-25(15-27-23)18-14-28-30(3)16-18/h6-7,10-17,26H,8-9H2,1-5H3

Substance Classes

Synthesis Path







Substances Referenced in Synthesis Path

CAS-RN Formula Chemical Name CAS Index Name
C8H5BrN2O 7-bromo-2(1H)-quinoxazolinone
C10H17BN2O2 1-methyl-4-(4,4,5,5-tetramethyl- 1,3,2-dioxaborolan-2-yl)-1H-pyrazole
1083325-87-4 C12H9BrN4 7-bromo-2-(1-methyl-1H-pyrazol-4-yl)quinoxazoline
C3H9N isopropylamine
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem

Trade Names

Country Trade Name Vendor Annotation
USA Lorem Lorem
(wfm = withdrawn from market)

Formulations

  • Loremipsumdolorsitamet,consetetur

References

    • Perera, T.P.S. et al., Molecular Cancer Therap., (2017) 16/6, 1010-1020.
    • WO 9999 999999 (Astex Therap.; 3.11.2011; appl. 28.4.2011; USA-prior. 30.4.2010).
    • US 9 999 999 (Astex Therap.; 25.11.2014; appl. 28.11.2011; USA-prior. 30.4.2010).
    • US 9 999 999 (Astex Therap.; 11.10.2016; appl. 2.10.2014; GB-prior. 30.4.2010).
  • Combinations:

    • US 9999 9999999 (Astex Therap.; 13.4.2017; appl. 26.3.2015; EP-prior. 26.3.2014).